| Aug 9 |
Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated
|
| Aug 9 |
Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down
|
| Aug 8 |
Catalyst (CPRX) Rises as Q2 Earnings & Revenues Beat Estimates
|
| Aug 7 |
Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues
|
| Aug 6 |
Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised
|
| Aug 6 |
Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist
|
| Aug 5 |
IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024
|
| Jul 25 |
Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
|
| Jul 24 |
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
|
| Jul 16 |
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
|
